e-learning
resources
Vienna 2003
Sunday 28.09.2003
Sleep related breathing disorders and control of breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nocturnal cardiac dysrhythmias induced by sleep apnoea in adults with or without hypertension and coronary artery disease
Z. Tomori, E. Szaboova, V. Donic (Kosice, Slovakia)
Source:
Annual Congress 2003 - Sleep related breathing disorders and control of breathing
Session:
Sleep related breathing disorders and control of breathing
Session type:
Poster Discussion
Number:
1184
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Tomori, E. Szaboova, V. Donic (Kosice, Slovakia). Nocturnal cardiac dysrhythmias induced by sleep apnoea in adults with or without hypertension and coronary artery disease. Eur Respir J 2003; 22: Suppl. 45, 1184
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018
Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006
Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease
Source: International Congress 2017 – CPAP therapy
Year: 2017
Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Changes in extracranial arteries in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 69-74
Year: 2005
Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017
Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017
Year: 2017
Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Obstructive sleep apnoea and coronary artery disease
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016
Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006
High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016
Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001
Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021
Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 115s
Year: 2005
Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept